China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.610
0.00 (0.00%)
Aug 14, 2025, 11:44 AM - Market open

China SXT Pharmaceuticals Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
1.741.931.972.64.78
Upgrade
Revenue Growth (YoY)
-9.73%-2.19%-24.23%-45.53%-7.45%
Upgrade
Cost of Revenue
1.371.371.551.351.94
Upgrade
Gross Profit
0.370.550.431.252.84
Upgrade
Selling, General & Admin
3.052.655.686.445.04
Upgrade
Operating Expenses
3.052.655.686.445.04
Upgrade
Operating Income
-2.68-2.09-5.26-5.19-2.2
Upgrade
Interest Expense
-0.84-0.55-0.48-0.04-1.12
Upgrade
Interest & Investment Income
0.190.01-00.01
Upgrade
Other Non Operating Income (Expenses)
0.03-0.040.15-0.180.36
Upgrade
EBT Excluding Unusual Items
-3.3-2.68-5.59-5.41-2.94
Upgrade
Asset Writedown
--0.42-0.35--
Upgrade
Pretax Income
-3.3-3.1-5.93-5.41-2.94
Upgrade
Income Tax Expense
---0.33-0.19
Upgrade
Net Income
-3.3-3.1-5.93-5.74-2.75
Upgrade
Net Income to Common
-3.3-3.1-5.93-5.74-2.75
Upgrade
Shares Outstanding (Basic)
100--
Upgrade
Shares Outstanding (Diluted)
100--
Upgrade
Shares Change (YoY)
1212.67%224.91%---
Upgrade
EPS (Basic)
-2.32-28.58-177.84--
Upgrade
EPS (Diluted)
-2.32-28.58-177.84--
Upgrade
Free Cash Flow
-2.35-1.94-0.150.21-1.41
Upgrade
Free Cash Flow Per Share
-1.65-17.85-4.54--
Upgrade
Gross Margin
21.11%28.73%21.62%48.10%59.44%
Upgrade
Operating Margin
-153.97%-108.49%-266.68%-199.43%-45.99%
Upgrade
Profit Margin
-189.77%-160.67%-301.00%-220.43%-57.52%
Upgrade
Free Cash Flow Margin
-134.83%-100.34%-7.68%7.91%-29.50%
Upgrade
EBITDA
-2.6-1.89-5.01-4.87-1.85
Upgrade
EBITDA Margin
-149.24%-97.95%-253.99%-187.13%-38.76%
Upgrade
D&A For EBITDA
0.080.20.250.320.35
Upgrade
EBIT
-2.68-2.09-5.26-5.19-2.2
Upgrade
EBIT Margin
-153.97%-108.49%-266.68%-199.43%-45.99%
Upgrade
Revenue as Reported
1.741.931.972.64.78
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q